 |
| Abualbishr Alshreef |
HEDS Research Fellow Abualbishr Alshreef has led on a research collaboration on assessing the appropriateness of model adaptation methods to the context of low and middle-income countries. The research is a collaboration between the University of Sheffield, University of Leeds, University of York,
Imperial College London, University of the Witwatersrand and National Department
of Health (South Africa).
Findings from the case
study on the cost-effectiveness of docetaxel and paclitaxel-containing
chemotherapy regimens based on model adaptation from UK to South Africa is published in Value in Health Regional Issues. The study represents an independent
research funded by the White Rose Collaboration Fund.
The study found
that “docetaxel and paclitaxel are predicted to be cost-effective as adjuvant
treatment for early breast cancer in South Africa”.
The study
highlighted that “model adaptation from high-income countries to middle-income
countries contexts is possible but not easy and may need considerable resources”.
HEDS contributions to this paper are from Abualbishr Alshreef, Sue Ward and
Simon Dixon.
For the full
paper, please click here https://authors.elsevier.com/sd/article/S2212109919300470